Курс First Convicted RACCONFRED

$ZOO has broken the downtrend in 1W and 1D candles and will be eyeing the resistence at 0.00002 from here on keep buying in patches and load your bags for 5× returns from here. with coming announcements about new features and upgrades due in coming days this low MCAP $ZOO is poised for growth.DYOR $ETH $BTC $SOL $BNB $BGB $TON $SOON $BUBB $PROMPT $BABY $FHE $XPR $PI $TRUMP $KILO $RIFSOL $FRED $DOGE $XRP

$ZOO has broken the downtrend in 1W and 1D candles and will be eyeing the resistence at 0.00002 from here on keep buying in patches and load your bags for 5× returns from here. with coming announcements about new features and upgrades due in coming days this low MCAP $ZOO is poised for growth.DYOR $ETH $BTC $SOL $BNB $BGB $TON $SOON $BUBB $PROMPT $BABY $FHE $XPR $PI $TRUMP $KILO $RIFSOL $FRED $DOGE $XRP

$ZOO has broken the downtrend in 1W and 1D candles and will be eyeing the resistence at 0.00002 from here on keep buying in patches and load your bags for 5× returns from here. DYOR $ETH $BTC $SOL $BNB $BGB $TON $SOON $BUBB $PROMPT $BABY $FHE $XPR $PI $TRUMP $KILO $RIFSOL $FRED $DOGE $XRP

$FRED 🔥⬆️⬆️⬆️

Fred Ehrsam and Brian Armstrong started Coinbase in a two-bedroom apartment thirteen years ago. Both men are now billionaires, but Ehrsam has quietly parlayed his fortunes into neuroscience innovation, launching a brain interface startup in 2024 called Nudge. On Monday, the firm unveiled its first product, the Nudge Zero, a non-invasive ultrasound neuromodulation device. That’s a mouthful, but “non-invasive ultrasound neuromodulation” simply means modifying brain activity by using an ultrasound machine. Such a device emits ultrasound waves that impact cell membranes in the brain without causing permanent changes or damage. (The “Nudge Zero” is the first device from Fred Ehrsam’s neuroscience startup / Nudge on X) Reasons for using ultrasound neuromodulation devices vary, but they typically fall into two overlapping categories, medical and therapeutic. Medical issues would include neurological conditions such as epilepsy and pain management, while therapeutic conditions would encompass less acute scenarios such as depression. The Nudge Zero, according to Ehrsam, will first tackle acute medical conditions, and its predecessor will eventually be introduced as a therapeutic solution for individuals seeking various forms of mental well-being. “We will first use the device to attempt to treat acute medical conditions in the coming months,” Ehrsam explained. “With the eventual goal of creating a headphone-like miniaturized version … to enhance mood, cognition, and daily life for healthy people.” (Computer renderings of what Nudge’s therapeutic wearables may look like once launched / Nudge on X) Prior to launching Nudge in 2024, Ehrsam and Sequioa veteran Matt Huang co-founded Paradigm in 2018, a crypto-focused venture capital firm that manages three funds, the most recent of which closed at $850 million last June. The 36-year-old Ehrsam, now worth $2.1 billion, according to Forbes, stepped away from his managing partner role at the firm in 2023 but has remained at Paradigm as a general partner. It appears neuroscience and not crypto is now his primary focus. “We believe improving the human experience is the most important thing to work on. This should be the goal of technology,” Ehrsam said. “And building technologies to interface with the brain is the most direct way of doing so.” 免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。